Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2759 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 307.0 | 79 | |
N2759 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 343.0 | 73 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 351.0 | 77 | |
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 338.5 | 114 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 249.0 | 101 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 357.0 | 99 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 408.0 | 77 | |
RA1869 | TNF-a | 100 | ng/mL | 3 | GM-CSF | 406.0 | 80 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 363.0 | 63 | |
N2759 | TNF-a | 100 | ng/mL | 3 | GM-CSF | 371.0 | 54 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 386.0 | 83 | |
RA1931 | TNF-a | 100 | ng/mL | 3 | GM-CSF | 378.0 | 69 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 395.0 | 77 | |
N2586 | TNF-a | 100 | ng/mL | 3 | GM-CSF | 402.0 | 91 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | GM-CSF | 224.0 | 82 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | GM-CSF | 225.0 | 80 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | GM-CSF | 231.5 | 84 | ||||
N2759 | IKK16 | 2.0 | uM | 3 | GM-CSF | 193.0 | 77 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | GM-CSF | 240.0 | 89 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | GM-CSF | 220.0 | 85 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | GM-CSF | 222.0 | 63 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | GM-CSF | 228.0 | 90 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | GM-CSF | 224.0 | 65 | ||||
RA1869 | 3 | GM-CSF | 209.0 | 78 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 3 | GM-CSF | 257.0 | 76 |